{"id":4556,"date":"2020-05-14T08:13:09","date_gmt":"2020-05-14T06:13:09","guid":{"rendered":"https:\/\/www.toulouse-white-biotechnology.com\/insights\/actualites\/actualite\/ibisba-4th-open-call\/"},"modified":"2026-03-16T14:27:42","modified_gmt":"2026-03-16T13:27:42","slug":"ibisba-4th-open-call","status":"publish","type":"post","link":"https:\/\/www.toulouse-white-biotechnology.com\/en\/insights\/blog\/ibisba-4th-open-call\/","title":{"rendered":"IBISBA : 4th Open Call"},"content":{"rendered":"\n<p align=\"left\"><span style=\"color: #000000;\"><a href=\"https:\/\/www.toulouse-white-biotechnology.com\/app\/uploads\/2020\/05\/image_4thopencall_ibisba-2.png\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-9905 alignleft\" src=\"https:\/\/www.toulouse-white-biotechnology.com\/app\/uploads\/2020\/05\/image_4thopencall_ibisba-300x150-3.png\" alt=\"\" width=\"300\" height=\"150\" \/><\/a>IBISBA 4th Open Call is opened from 11 May to 3 july 2020. It is promoted as a part of the IBISBA<strong>\u00a0Transnational Access (TNA)<\/strong>\u00a0Programme.<\/span><\/p>\n<p><span style=\"color: #000000;\">Projects that are well aligned with the aims of IBISBA and meet technical, scientific and ethical requirements will receive subsidised services and a contribution to travel and subsistence costs*.<\/span><\/p>\n<p><span style=\"color: #000000;\"><em>*Due to the current covid-19 situation, travel to the IBISBA facilities might be subject to restrictions.<\/em><\/span><\/p>\n<p><span style=\"color: #000000;\">Users are either researchers from\u00a0Academia,\u00a0Public Sector Research Centres\u00a0or\u00a0Industry, working either in\u00a0EU Member States\u00a0or\u00a0Associated Countries\u00a0and (more exceptionally)\u00a0<a style=\"color: #000000;\" href=\"https:\/\/www.employland.de\/knowledge\/eu-efta-and-third-countries\" target=\"_blank\" rel=\"noopener noreferrer\">Third Countries<\/a>. They are engaged in the conception or creation of new knowledge, products, processes, methods and systems, and also in the management of projects.<\/span><\/p>\n<h2>The IBISBA DBTLP cycle service offer<\/h2>\n<p><span style=\"color: #000000;\">Applicants may choose from the categories Design, Build, Test, Learn, Process and request up to 3 facility services in the field of: Synthetic Biology ; Genetcis, Biochemistry ; Bioinformatics, Biomedical ; Food Production ; Energy ; Environmentel Biotechnology &amp; Remediation.<\/span><\/p>\n<p><span style=\"color: #000000;\"><strong>TWB offers services linked to her platforms :<\/strong><\/span><\/p>\n<ul>\n<li><strong>Strain engineering (construction, screening, evolution);<\/strong><\/li>\n<li><strong>Bioprocess : fermentation, analytical.<\/strong><\/li>\n<\/ul>\n<p><span style=\"color: #000000;\">Please, ensure that you consult the\u00a0<a style=\"color: #000000;\" href=\"https:\/\/www.ibisba.eu\/Our-Offer\/Subsidised-Access\/Application\" target=\"_self\" rel=\"noopener noreferrer\"><strong>application guidelines and other important documents<\/strong><\/a>.<\/span><\/p>\n<p><span style=\"color: #000000;\">Deadline: <strong>3 July 2020<\/strong> 17.00 (Brussels time)<\/span><\/p>\n<h2>IBISBA Reminder<\/h2>\n<p><span style=\"color: #000000;\">Launched in 2015 with INRAE, the European initiative Industrial Biotechnology Innovation and Synthetic Biology Acceleration (IBISBA) is a programme to bring together European infrastructures to support and accelerate industrial biotechnology projects. The network brings together several platforms covering the entire research process from the design phases to production. IBISBA aims to coordinate the action of these platforms in order to remove the biological and technological obstacles encountered in the development of an industrial bioprocess. This project brings together 14 infrastructures from 9 European countries, including VVT (Finland), RWTH Aachen University, Fraunhofer IGB\/CBP (Germany) and Manchester Institute of Biotechnology (United Kingdom).<\/span><\/p>\n<p><span style=\"color: #000000;\">Focusing on the different R&amp;D phases in the development of bioprocess, IBISBA offers services related to the computer-aided design of biomolecules, the construction of enzymes and microbial strains, fermentation, downstream processing steps and the management of the project knowledge assets.<\/span><\/p>\n<p><span style=\"color: #000000;\">The European Commission (EC) has incorporated this infrastructure in its ESFRI (European Strategy Forum on Research Infrastructures) roadmap and approved in August 2019 the &#8220;PREP-IBISBA&#8221; project, aiming to set up this research infrastructure as an autonomous legal entity with its business model, business plan and scientific roadmap, with funding of \u20ac4 million over 4 years.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":4695,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_schema_org_content_json":"","footnotes":""},"categories":[5],"tags":[30,28,115],"class_list":["post-4556","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite","tag-biotech","tag-biotechnology","tag-ibisba"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/posts\/4556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/comments?post=4556"}],"version-history":[{"count":1,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/posts\/4556\/revisions"}],"predecessor-version":[{"id":4691,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/posts\/4556\/revisions\/4691"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/media\/4695"}],"wp:attachment":[{"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/media?parent=4556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/categories?post=4556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/tags?post=4556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}